OverviewChartTechnicalNewsTraderScreen

ImmuCell Corporation/  US4525253062  /

NASDAQ
2024-04-16  8:32:42 PM Chg. +0.0199 Volume Bid8:33:05 PM Ask8:33:05 PM High Low
5.0899USD +0.39% 4,384
Turnover: 20,783.1600		 5.0500Bid Size: 500 5.0900Ask Size: 200 5.1600 5.0400
GlobeNewswire 04-09 ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
GlobeNewswire 02-27 ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
GlobeNewswire 02-16 ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
GlobeNewswire 01-08 ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
GlobeNewswire 2023-11-13 ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
GlobeNewswire 2023-11-07 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
GlobeNewswire 2023-10-05 ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
GlobeNewswire 2023-08-29 ImmuCell Announces Submission of CMC Technical Section to the FDA
GlobeNewswire 2022-02-22 ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
GlobeNewswire 2022-02-16 ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
GlobeNewswire 2022-01-05 ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021
GlobeNewswire 2021-11-15 ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021
GlobeNewswire 2021-11-09 ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021
GlobeNewswire 2021-10-06 ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021
GlobeNewswire 2021-09-14 Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team
GlobeNewswire 2021-09-01 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corpora...
GlobeNewswire 2021-08-24 ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
GlobeNewswire 2021-08-12 ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
GlobeNewswire 2021-08-05 ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021
GlobeNewswire 2021-07-07 ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021
GlobeNewswire 2021-05-19 ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
GlobeNewswire 2021-05-13 ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021
GlobeNewswire 2021-05-06 ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021
GlobeNewswire 2021-04-14 ImmuCell Closes $4,250,000 Equity Financing
GlobeNewswire 2021-04-07 ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021